Target intelligence / Profile preview

Novel transcript, sense intronic to NFAT5

Molecular classification
Non-coding RNA (Intronic lncRNA), Not part of the major protein target families (e.g., receptor, ion channel, enzyme, transporter, transcription factor, histone modification)
01

Overview

"Novel transcript, sense intronic to NFAT5" (ENSG00000274093) refers to a non-coding RNA transcribed from within the NFAT5 gene region, located on chromosome 16. Unlike protein-coding genes or classic therapeutic targets, this transcript does not encode a protein and has no established role in molecular classification systems for drug targets. Its biological function is uncharacterized; it may play a regulatory role within the NFAT5 locus, potentially affecting NFAT5 expression or splicing, but there is no direct evidence in current literature. It is not an established target for intervention in human disease, nor is it a biomarker or subject to current safety concern discussions. By contrast, NFAT5 itself is a stress-responsive transcription factor involved in osmotic regulation, immune response, and disease, but the intronic sense transcript is distinct from protein-coding or actionable RNA targets in current biomedical frameworks[1][3][5].

Other names
ENSG00000274093 (Ensembl gene ID)Intronic non-coding RNA within NFAT5Sense intronic transcript of NFAT5
02

Mechanism of action

Not applicable; no drugs target this transcript

03

Biological functions

UnknownPossibly regulatory (as some intronic transcripts can modulate their host gene expression), but there is no published evidence specifically assigning function to ENSG00000274093 [3][5]Other
04

Disease associations

None established for this transcriptOther
05

Safety considerations

None reported; targeting or manipulating this transcript is not established in clinical or research settings
06

Interacting drugs

None known; no drugs reported to specifically target this transcript
07

Biomarkers

None described for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Novel transcript, sense intronic to NFAT5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to NFAT5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call